Annual Report 2015 From neglected diseases to neglected populations and patients Download PDF Browse Online Annual Report Sections Vision, Mission & Strategy An unchanged vision, an expanded mission: with its new dynamic portfolio approach, DNDi remains responsive to evolving research and patient needs. Insight by the Chair of the Board of Directors and the Executive Director. R&D Model & Portfolio DNDi now has 15 new compounds in its R&D portfolio. These could lead to brand new treatments, building on DNDi’s short-term strategies to improve existing therapies by targeting immediate unaddressed patient needs. Strengthening Existing Capacities True to its vision and mission, DNDi continues to be actively involved in research platforms in endemic countries, while developing new networks for diseases that were recently added to its portfolio. Advocacy, Communications & Fundraising Medical innovation is on the political agenda like never before: in 2015, DNDi spoke of the lessons learnt from its model and how they might apply to various initiatives to re-orient the global biomedical R&D system. Financial Report With EUR 43 million budget in 2015, growth is steady, and the funding strategy balanced and diversified to ensure DNDi’s financial independence.